Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Postmarket Surveillance Needed For Mallinckrodt OxiSure, FDA Panel Says

Jan 31 2000

Related Content

Intrapartum fetal oximetry monitor studies should measure C-section rate -- FDA guidance.

Jun 30 1997

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window